Abstract
Just over 20 years ago, an innovation occurred in agriculture-one with global implications. From this modest beginning, agricultural biotechnology and GM crops have become nothing short of the most rapidly, and widely, adopted innovation in the history of commodity agriculture. This book aims to provide an overview of socio-economic considerations (SEC) assessment in biotechnology regulation as a resource for policy makers and other interested stakeholders concerned with the development of best practice, methods and policy guidelines for SEC evaluation implementation and inclusion in decision making. This chapter sets the scene for the remainder of the chapters.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
UNEP/CBD/BS/WS-SEC/1/3 (18 October 2011)
- 2.
UNEP/CBD/BS/COP-MOP/6/15 Socio-Economic Considerations (Article 26) 28 July 2012.
- 3.
OJ L 106, 17 April 2001.
References
UNEP/CBD/BS/WS-SEC/1/3 (18 October 2011) Synthesis of information on national experiences with socio-economic considerations in decision-making on living modified organisms
UNEP/CBD/BS/COP-MOP/5/INF/10 (17 September 2010) Summary Report on the Survey on the Application of and Experience in the Use of Socio-Economic Considerations in Decision-Making on Living Modified Organisms
Brookes G (2009) Socio-economic impacts of GM crop technology: ‘second round’ impacts. Briefing note, UK
COGEM (2009) Socio-economic aspects of GMOs. Building Blocks for an EU Sustainability Assessment of Genetically Modified Crops. COGEM Report CGM/090929-01. http://www.cogem.net/main-adviesdetail-signaleringEN.aspx?pageid=54&loc=2&version=&mode=&id=517. Accessed 7 June 2013
Ebbels DL (2003) Principles of plant health and quarantine. CABI Publishing http://www.corpoica.org.co/SitioWeb/WebBac/Documentos/Principlesofplanthealthandquarantine.pdf. Accessed 7 June 2013
European Commission, COM (2011) Final Report from the Commission to the European Parliament and the Council on socio-economic implications of GMO cultivation on the basis of Member States contributions, as requested by the Conclusions of the Environmental Council of Dec 2008
Falck Zepeda JB (2009) Socio-economic considerations, Article 26.1 of the Cartagena Protocol on Biosafety: what are the issues and what is at stake? AgBioForum 12(1):90–107. http://agbioforum.org/v12n1/v12n1a09-falckzepeda.htm. Accessed 7 June 2013
Falck Zepeda J, Wesseler J, Smyth S (2010) The current status of the debate on socio-economic assessments and biosafety highlighting different positions and policies in Canada and the US, the EU and Developing Countries. Paper presented at World Congress of Environmental and Resource Economics (WCERE), Montreal, Canada, 29 June
Fransen L, La Vina A, Dayrit F et al (2005) Integrating socio-economic considerations into biosafety decisions: the role of public participation. World Resources Institute, Washington, DC, USA
Hope J (2001) New Zealand Royal Commission on genetic modification. Environmental and Planning Law Journal 18(5):441–444
IISD (International Institute for Sustainable Development) (2012) Sixth meeting of the Conference of the Parties to the Convention on Biological Diversity (CBD) serving as the meeting of the Parties to the Cartagena Protocol on Biosafety (COP/MOP 6). Earth Negotiations Bulletin 1–5 October, http://www/iisd.ca/download/pdf/enb09585e.pdf. Accessed 30 Oct 2012
Jaffe G (2005) Implementing the Cartagena Biosafety Protocol through national biosafety regulatory systems: an analysis of key unresolved issues. J Publ Aff 5:299–311
James C (2010) Global status of commercialized biotech/GM crops: 2010. ISAAA Brief No 42. ISAAA, Ithaca, NY, USA
James C, Krattiger AF (1996) Global review of the field testing and commercialization of transgenic plants, 1986–1995: the first decade of crop biotechnology. ISAAA Brief 1. International Service for the Acquisition of Agri-biotech Applications, Ithica, NY, USA
Jarvis A (2009) A way forward for GMO cultivation in Europe? Chatham House Programme Paper, Nov
La Vina A, Fransen L (2004) Integrating socio-economic considerations into biosafety decisions: the challenge for Asia. Paper for IUCN-IDRC Meeting on Biosafety, Sri Lanka
Moses LB (2007) Recurring dilemmas: the law’s race to keep up with technological change. U Ill JL Tech & Policy 7:239–285
New Zealand ERMA (1999) Technical Guide Identifying Risks for applications under the Hazardous Substances and New Organisms Act 1996 (ER-TG-01-1 9/99)
New Zealand ERMA (2009) Decision making. A technical guide to identifying, assessing and evaluating risks, costs and benefits. ER-TG-05-02 03/09
Schefer KN (2010) Social regulation in the WTO. Trade policy and international legal development. Edward Elgar, UK
Smyth S, Falck-Zepeda J (2012) Socio-economic considerations and international trade agreements. International Political Science Association Conference, Madrid, Spain, 8–12 July
Third World Network (2008) Assessing the socio-economic, cultural and ethical impacts of GMOs. Third World Network Briefings for MOP 4#3
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ludlow, K., Smyth, S., Falck-Zepeda, J. (2014). Introduction to Socio-Economic Considerations in the Regulation of Genetically Modified Organisms. In: Ludlow, K., Smyth, S., Falck-Zepeda, J. (eds) Socio-Economic Considerations in Biotechnology Regulation. Natural Resource Management and Policy, vol 37. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9440-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9440-9_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9439-3
Online ISBN: 978-1-4614-9440-9
eBook Packages: Business and EconomicsEconomics and Finance (R0)